Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

BioZone Pharmaceuticals Inc.

Division of Cocrystal Pharma Inc.
www.biozonelabs.com

Latest From BioZone Pharmaceuticals Inc.

Finance Watch: Opko's Stock Halted As Nasdaq Awaits An Explanation For SEC Pump-And-Dump Lawsuit

Public Company Edition: An SEC complaint alleges that the company, Opko CEO Frost and co-defendants bought penny stocks, pumped up their value, then dumped shares for sizeable profits. Also, Pfizer and Retrophin float debt offerings, while Zealand sells royalties and milestone fees to raise cash.

Financing Regulation

MusclePharm Maintains NASDAQ Goal Despite SEC Investigation

The sports nutrition supplement marketer’s latest earnings statement includes the sort of sales and loss figures that have grabbed SEC’s attention and made some investors leery of the firm’s shares, which currently are traded over-the-counter.

Consumer United States

MusclePharm Maintains NASDAQ Goal Despite SEC Investigation

The sports nutrition supplement marketer’s latest earnings statement includes the sort of sales and loss figures that have grabbed SEC’s attention and made some investors leery of the firm’s shares, which currently are traded over-the-counter.

Consumer United States

Deals Shaping The Medical Industry, February 2014

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced December 2013 through January 2014.

BioPharmaceutical Medical Device
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Drug Delivery
    • OTC, Consumer
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Cocrystal Pharma Inc.
  • Senior Management
  • Elliot M Maza, CEO & CFO
    Brian Keller, Pres. & CSO
  • Contact Info
  • BioZone Pharmaceuticals Inc.
    Phone: (201) 608-5101
    550 Sylvan Ave., Ste. 101
    Englewood Cliffs, NJ 07632
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register